semaglutide market Size, Share, Demand, Forecast, 2034 Semaglutide Market Size, Share and

The potential impact on their business specifically, and their sector more broadly, based on their product/service mix, customer profiles and geographic focus

This means the FDA is now (finally!) coming after the entire compounded GLP-1 market, including the injectable business that HIMS and others have been operating profitably for over a year since the semaglutide shortage was officially resolved in early 2025, largely without meaningful enforcement

The longer you have T1D, the greater your risk for complications including heart and kidney disease nerve damage, and vision problems

Some patients report less nausea when injecting during eating windows, while others tolerate injection fine during fasts

Abundant evidence revealed that liver fibrosis is a key factor determining clinical outcomes in NASH patients (128)